Font: Financial Modeling Prep • Aug 13, 2026
On August 13, 2026, investment firm Goldman Sachs (NYSE: GS) downgraded its rating on Advanced Micro Devices (NASDAQ: AMD) to Sell from Buy. AMD, a leading semiconductor company, is a global entity that designs cutting-edge computer processors and graphics technologies. It stands as a major competitor to companies like Intel (NASDAQ: INTC) in the crucial server and personal computer markets.
This stock downgrade occurs even as AMD reports robust financial performance. The company achieved record second-quarter revenue of $11.54 billion, marking a 50% increase year over year. This significant revenue growth is primarily driven by its Data Center segment, which now represents 58% of the company's total sales, highlighting AMD's strength in high-growth markets.
In contrast to the Goldman Sachs downgrade, some market analysts maintain a positive outlook on AMD. For example, Bernstein analyst Stacy Rasgon holds a "Buy" rating and raised the firm's 12-month price target to $650.00 from $525.00. A price target is an analyst's projection of a stock's future price over a specific period, reflecting their investment analysis.
This analyst optimism is further supported by AMD's strong third-quarter guidance, which projects revenue of $13.0 billion. The semiconductor giant also expects to continue gaining server CPU market share from Intel. As highlighted by Seeking Alpha, significant AI commitments from major tech companies like Microsoft (NASDAQ: MSFT) and Meta (NASDAQ: META) also bolster this positive investment outlook for AMD.
However, some market observers express caution regarding AMD stock. Seeking Alpha has issued a "Hold" rating on the stock, citing industry volatility and near-term market risks. These risks include ongoing supply chain disruptions and a shortage of RAM, which could impact AMD's future performance despite the company's current strong results in the chip market.
|
MDXH§>
MDxHealth S.A.
|
$0.97
110.74%
|
|
SURG§>
SurgePays, Inc.
|
$0.31
27.29%
|
|
VBIO§>
Valion Bio, Inc.
|
$0.21
24.18%
|
|
NU§>
Nu Holdings Ltd.
|
$15.07
8.18%
|
|
TSLL§>
Direxion Daily TSLA Bull 2X ETF
|
$8.62
-0.23%
|
|
ONFO§>
Onfolio Holdings, Inc.
|
$3.12
34.85%
|
|
CYCU§>
Cycurion, Inc. Common Stock
|
$0.68
-3.16%
|
|
ONDS§>
Ondas Holdings Inc.
|
$9.14
2.53%
|
|
OTLK§>
Outlook Therapeutics, Inc.
|
$0.77
-13.85%
|
|
SPCX§>
Space Exploration Technologies Corp.
|
$139.36
-1.37%
|